Cat.#: ACPP-1213
| Despition | CACNB2 Blocking Peptide for Immmunodepletion, Competition Assay |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1742 | Human PRND Protein (AC1742) | 2 µg | inquiry |
| ACPP-1218 | Dopamine D2 Receptor Blocking Peptide (AC1218) | 250 µg | inquiry |
| ACPP-1664 | Human BLMH Protein (AC1664) | 5 µg | inquiry |
| ACPP-1658 | Human Acrp30 Protein, His (AC1658) | 10 µg | inquiry |
| ACPP-1753 | Human SPR Protein (AC1753) | 5 µg | inquiry |
| ACPP-1536 | Human EFNB1 Protein (AC1536) | 5 µg | inquiry |
| ACPP-1362 | MERTK Blocking Peptide (AC1362) | 250 µg | inquiry |
| ACPP-1328 | MRAP2 Blocking Peptide (AC1328) | 250 µg | inquiry |
| ACPP-1415 | Human GNAQ Protein (AC1415) | 5 µg | inquiry |
| ACPP-1404 | Human p59-Fyn Protein (AC1404) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.